CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

 
  FY 2015 FY 2016 FY 2017 FY 2018 FY 2019(Est.)
Net Sales 9,650 10,003 10,393 10,796 10,930

Cost of Sales
(% of Net Sales)

5,438
56.4%
5,499
55.0%
5,471
52.6%
5,753
53.3%
5,739
52.5%

Gross Profit
(% of Net Sales)

4,211
43.6%
4,503
45.0%
4,922
47.4%
5,043
46.7%
5,191
47.5%

SG&A expenses
(% of Net Sales)

3,563
36.9%
3,748
37.5%
4,068
39.1%
4,049
37.5%
4,191
38.3%

Operating Income 
(% of Net Sales)

648
6.7%
754
7.5%
854
8.2%
993
9.2%
1,000
9.1%

Ordinary Income 
(% of Net Sales)

654
6.8%
821
8.2%
880
8.5%
999
9.3%
1,010
9.2%

Net Income
(% of Net Sales)

333
3.5%
516
5.2%
467
4.5%
672
6.2%
700
6.4%

Net Sales by Sales Format(cons.)

Unit:million yen

  FY 2015 FY 2016 FY 2017 FY 2018 FY 2019(Est.)

Own-brand
(%)

6,441
66.8%
6,263
62.6%
6,402
61.6%
6,558
60.7%
6,722
61.5%
OEM Sales
(%)
1,526
15.8%
1,784
17.8%
1,576
15.2%
1,522
14.1%
1,336
12.2%
Overseas
(%)
1,682
17.4%
1,954
19.6%
2,414
23.2%
2,715
25.2%
2,870
26.3%
Total
(%)
9,650
100.0%
10,003
100.0%
10,393
100.0%
10,796
100.0%
10,930
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2015 FY 2016 FY 2017 FY 2018 FY 2019(Est.)

Current Assets

10,708 11,433 11,126 11,159 12,071

Fixed Assets

6,482 6,178 6,133 6,078 5,621

Total Assets
(Gross Assets)

17,191 17,611 17,259 17,237 17,692

Current Liabilities

2,718 3,294 3,052 2,914 2,951

Fixed Liabilities

1,329 1,713 1,337 1,437 1,313

Total Liabilities

4,047 5,007 4,390 4,351 4,265

Shareholders' Equity

13,143 12,603 12,868 12,886 13,427

Equity Ratio

76.5% 71.6% 74.6% 74.8% 75.9%

Cash Flow Data

Unit:million yen

  FY 2015 Fy 2016 FY 2017 FY 2018 FY 2019
(Est.)

Net cash provided by (used in) operating activities

715 1,443 524 797 909

Net cash provided by (used in) investing activities

△ 492 △ 270 △ 193 △ 598 △ 267

Net cash provided by (used in) financing activities

△ 584 △ 332 △ 652 △ 585 △ 426

Net increase(decrease)in cash and cash equivalents

△ 431 719 △ 313 △ 484 215

Cash and cash equivalents at end of year

3,708 4,427 4,114 3,629 3,845

Free Cash Flow

223 1,173 331 199 641
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2015 FY 2016 FY 2017 FY 2018 FY 2019(Est.)
ROE 2.6% 4.0% 3.7% 5.2% 5.3%
EPS(yen) 34.64 54.73 50.23 72.20 75.14
BPS(yen) 1,366.83 1,352.97 1,381.40 1,383.31 1,441.41

Dividend per Share (yen)

35 35 35 37 37

Dividend Payout Ratio(cons.)

101.0% 64.0% 69.7% 51.2% 49.2%

TOP